Evotec AG, of Hamburg, Germany, said its wholly owned company, Cyprotex, has completed the relocation of its U.K. operations from Macclesfield to Alderley Park designed to consolidate operations into a single, state-of-the-art facility. The core capabilities include in vitro ADME services, mechanistic toxicology and high content toxicology screening services, and predictive modeling solutions.